- Home
- TDOC vs AMPH Comparison
TDOC vs AMPH Comparison
Compare TDOC & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDOC
- AMPH
- Stock Information
- Founded
- TDOC 2002
- AMPH 1996
- Country
- TDOC United States
- AMPH United States
- Employees
- TDOC N/A
- AMPH N/A
- Industry
- TDOC Medical/Nursing Services
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- TDOC Health Care
- AMPH Health Care
- Exchange
- TDOC Nasdaq
- AMPH Nasdaq
- Market Cap
- TDOC 1.2B
- AMPH 1.1B
- IPO Year
- TDOC 2015
- AMPH 2014
- Fundamental
- Price
- TDOC $6.76
- AMPH $25.72
- Analyst Decision
- TDOC Buy
- AMPH Hold
- Analyst Count
- TDOC 19
- AMPH 5
- Target Price
- TDOC $9.60
- AMPH $38.00
- AVG Volume (30 Days)
- TDOC 4.9M
- AMPH 566.0K
- Earning Date
- TDOC 04-30-2025
- AMPH 05-07-2025
- Dividend Yield
- TDOC N/A
- AMPH N/A
- EPS Growth
- TDOC N/A
- AMPH N/A
- EPS
- TDOC N/A
- AMPH 2.77
- Revenue
- TDOC $2,552,812,000.00
- AMPH $730,659,000.00
- Revenue This Year
- TDOC N/A
- AMPH $0.65
- Revenue Next Year
- TDOC $1.32
- AMPH $5.26
- P/E Ratio
- TDOC N/A
- AMPH $9.30
- Revenue Growth
- TDOC N/A
- AMPH 8.05
- 52 Week Low
- TDOC $6.35
- AMPH $22.64
- 52 Week High
- TDOC $15.21
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- TDOC 40.40
- AMPH 55.38
- Support Level
- TDOC $6.71
- AMPH $25.15
- Resistance Level
- TDOC $7.34
- AMPH $25.72
- Average True Range (ATR)
- TDOC 0.27
- AMPH 0.70
- MACD
- TDOC -0.01
- AMPH 0.22
- Stochastic Oscillator
- TDOC 5.88
- AMPH 85.71
About TDOC Teladoc Health Inc.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.